• 631 Citations
  • 13 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Drug Therapy Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
T-Cell Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 631 Citations
  • 13 h-Index
  • 113 Article
  • 18 Review article
  • 1 Comment/debate

A conveniently synthesized Pt (IV) conjugated alginate nanoparticle with ligand self-shielded property for targeting treatment of hepatic carcinoma

Wang, X., Chang, Z., Nie, X., Li, Y., Hu, Z. P., Ma, J., Wang, W., Song, T., Zhou, P., Wang, H. & Yuan, Z., Jan 1 2019, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 15, 1, p. 153-163 11 p.

Research output: Contribution to journalArticle

Glycyrrhetinic Acid
Cardiovascular system
Cardiovascular System
19 Citations

Chidamide in relapsed or refractory peripheral T cell lymphoma: A multicenter real-world study in China

Shi, Y., Jia, B., Xu, W., Li, W., Liu, T., Liu, P., Zhao, W., Zhang, H., Sun, X., Yang, H., Zhang, X., Jin, J., Jin, Z., Li, Z., Qiu, L., Dong, M., Huang, X., Luo, Y., Wang, X., Wang, X. & 38 othersWu, J., Xu, J., Yi, P., Zhou, J., He, H., Liu, L., Shen, J., Tang, X., Wang, J., Yang, J., Zeng, Q., Zhang, Z., Cai, Z., Chen, X., Ding, K., Hou, M., Huang, H-Q., Li, X., Liang, R., Liu, Q., Song, Y., Su, H., Gao, Y., Liu, L., Luo, J., Su, L., Sun, Z., Tan, H., Wang, H., Wang, J., Wang, S., Zhang, H., Zhang, X., Zhou, D., Bai, O., Wu, G., Zhang, L. & Zhang, Y., Mar 15 2017, In : Journal of Hematology and Oncology. 10, 1, 69.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Drug Therapy
1 Citations
Non-Hodgkin's Lymphoma
2 Citations

Synergistic antitumor effect of histone deacetylase inhibitor and Doxorubicin in peripheral T-cell lymphoma

Zhang, H., Dong, L., Chen, Q., Kong, L., Meng, B., Wang, H., Fu, K., Wang, X., Pan-Hammarström, Q., Wang, P. & Wang, X., May 1 2017, In : Leukemia Research. 56, p. 29-35 7 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Histone Deacetylase Inhibitors
Pharmaceutical Preparations